Deubiquitinating activity of the SARS-CoV papain-like protease.
作者信息
Barretto Naina, Jukneliene Dalia, Ratia Kiira, Chen Zhongbin, Mesecar Andrew D, Baker Susan C
机构信息
Loyola University Chicago Stritch School of Medicine, Maywood, IL, USA.
出版信息
Adv Exp Med Biol. 2006;581:37-41. doi: 10.1007/978-0-387-33012-9_5.
Abstract
摘要
相似文献
1
Deubiquitinating activity of the SARS-CoV papain-like protease.
Adv Exp Med Biol. 2006;581:37-41. doi: 10.1007/978-0-387-33012-9_5.
2
The papain-like protease of severe acute respiratory syndrome coronavirus has deubiquitinating activity.
J Virol. 2005 Dec;79(24):15189-98. doi: 10.1128/JVI.79.24.15189-15198.2005.
3
The papain-like protease from the severe acute respiratory syndrome coronavirus is a deubiquitinating enzyme.
J Virol. 2005 Dec;79(24):15199-208. doi: 10.1128/JVI.79.24.15199-15208.2005.
4
Structural basis for catalysis and ubiquitin recognition by the severe acute respiratory syndrome coronavirus papain-like protease.
Acta Crystallogr D Biol Crystallogr. 2014 Feb;70(Pt 2):572-81. doi: 10.1107/S1399004713031040. Epub 2014 Jan 31.
5
Papain-like protease 2 (PLP2) from severe acute respiratory syndrome coronavirus (SARS-CoV): expression, purification, characterization, and inhibition.
Biochemistry. 2005 Aug 2;44(30):10349-59. doi: 10.1021/bi0504761.
6
The emerging SARS-CoV-2 papain-like protease: Its relationship with recent coronavirus epidemics.
J Med Virol. 2021 Mar;93(3):1581-1588. doi: 10.1002/jmv.26497. Epub 2020 Sep 28.
7
The SARS-coronavirus papain-like protease: structure, function and inhibition by designed antiviral compounds.
Antiviral Res. 2015 Mar;115:21-38. doi: 10.1016/j.antiviral.2014.12.015. Epub 2014 Dec 29.
8
Severe acute respiratory syndrome coronavirus papain-like protease: structure of a viral deubiquitinating enzyme.
Proc Natl Acad Sci U S A. 2006 Apr 11;103(15):5717-22. doi: 10.1073/pnas.0510851103. Epub 2006 Mar 31.
9
Inhibitor recognition specificity of MERS-CoV papain-like protease may differ from that of SARS-CoV.
ACS Chem Biol. 2015 Jun 19;10(6):1456-65. doi: 10.1021/cb500917m. Epub 2015 Mar 16.
10
Identification of severe acute respiratory syndrome coronavirus replicase products and characterization of papain-like protease activity.
J Virol. 2004 Dec;78(24):13600-12. doi: 10.1128/JVI.78.24.13600-13612.2004.
引用本文的文献
1
Synthesis and Structure-Activity Relationship of Covalent Inhibitors of SARS-CoV-2 Papain-Like Protease with Antiviral Potency.
Bioorg Med Chem Lett. 2025 Feb 1;116:130034. doi: 10.1016/j.bmcl.2024.130034. Epub 2024 Nov 21.
2
A Method to Monitor Activity of SARS-CoV-2 Nsp3 from Cells.
Methods Mol Biol. 2023;2591:269-282. doi: 10.1007/978-1-0716-2803-4_16.
3
Hydrazones and Thiosemicarbazones Targeting Protein-Protein-Interactions of SARS-CoV-2 Papain-like Protease.
Front Chem. 2022 Apr 11;10:832431. doi: 10.3389/fchem.2022.832431. eCollection 2022.
4
Host and Viral Zinc-Finger Proteins in COVID-19.
Int J Mol Sci. 2022 Mar 28;23(7):3711. doi: 10.3390/ijms23073711.
5
Evolution trace of SARS-CoV-2 from January 19 to March 12, 2020, in the United States.
J Med Virol. 2021 Dec;93(12):6595-6604. doi: 10.1002/jmv.27225. Epub 2021 Jul 28.
6
In search of drugs to alleviate suppression of the host's innate immune responses against SARS-CoV-2 using a molecular modeling approach.
In Silico Pharmacol. 2021 Apr 4;9(1):26. doi: 10.1007/s40203-021-00085-y. eCollection 2021.
7
Targeting SARS-CoV-2 viral proteases as a therapeutic strategy to treat COVID-19.
J Med Virol. 2021 May;93(5):2722-2734. doi: 10.1002/jmv.26814. Epub 2021 Feb 9.
8
Spatial and temporal roles of SARS-CoV PL -A snapshot.
FASEB J. 2021 Jan;35(1):e21197. doi: 10.1096/fj.202002271.
9
Structural insights into SARS-CoV-2 proteins.
J Mol Biol. 2021 Jan 22;433(2):166725. doi: 10.1016/j.jmb.2020.11.024. Epub 2020 Nov 24.
10
Strategies for Targeting SARS CoV-2: Small Molecule Inhibitors-The Current Status.
Front Immunol. 2020 Sep 18;11:552925. doi: 10.3389/fimmu.2020.552925. eCollection 2020.
本文引用的文献
1
The papain-like protease of severe acute respiratory syndrome coronavirus has deubiquitinating activity.
J Virol. 2005 Dec;79(24):15189-98. doi: 10.1128/JVI.79.24.15189-15198.2005.
2
Deubiquitination, a new function of the severe acute respiratory syndrome coronavirus papain-like protease?
J Virol. 2005 Apr;79(7):4550-1. doi: 10.1128/JVI.79.7.4550-4551.2005.
3
Identification of severe acute respiratory syndrome coronavirus replicase products and characterization of papain-like protease activity.
J Virol. 2004 Dec;78(24):13600-12. doi: 10.1128/JVI.78.24.13600-13612.2004.
4
Crystal structure of a UBP-family deubiquitinating enzyme in isolation and in complex with ubiquitin aldehyde.
Cell. 2002 Dec 27;111(7):1041-54. doi: 10.1016/s0092-8674(02)01199-6.
5
Coronavirus protein processing and RNA synthesis is inhibited by the cysteine proteinase inhibitor E64d.
Virology. 1995 Apr 1;208(1):1-8. doi: 10.1006/viro.1995.1123.
6
A human RNA viral cysteine proteinase that depends upon a unique Zn2+-binding finger connecting the two domains of a papain-like fold .
J Biol Chem. 1999 May 21;274(21):14918-25. doi: 10.1074/jbc.274.21.14918.
7
Crystal structure of a deubiquitinating enzyme (human UCH-L3) at 1.8 A resolution.
EMBO J. 1997 Jul 1;16(13):3787-96. doi: 10.1093/emboj/16.13.3787.
Zotero 插件